Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 22471579)

1.

Methadone treatment as palliation or an individualized process of recovery management?

Day E.

Addiction. 2012 May;107(5):953-4. doi: 10.1111/j.1360-0443.2012.03785.x. No abstract available.

PMID:
22471579
2.

Counselling during substitution treatment: not enough is too much?

Dunlop A.

Addiction. 2012 May;107(5):954-6. doi: 10.1111/j.1360-0443.2012.03842.x. No abstract available.

PMID:
22471580
3.

Methadone & heroin use: a survey of prisoners in police custody.

Jamieson RJ.

J Forensic Leg Med. 2011 Jul;18(5):233. doi: 10.1016/j.jflm.2011.04.007. Epub 2011 May 12. No abstract available.

PMID:
21663873
4.

[Methadone and naltrexone in heroin addiction--an explanation from the SBU].

Asplund K, Jonsson E.

Lakartidningen. 2002 Feb 7;99(6):552-3. Swedish. No abstract available.

PMID:
11881233
5.

Injectable methadone: cautious interest.

Torrens M.

Addiction. 2000 Dec;95(12):1864-5. No abstract available.

PMID:
11218365
6.

[All methadone therapy must be safer].

Nilsson LH.

Lakartidningen. 2010 May 5-11;107(18):1213-4. Swedish. No abstract available.

PMID:
20521592
7.

[Methadone dose, treatment duration and heroin use in drug-assisted rehabilitation].

Kornør H, Waal H.

Tidsskr Nor Laegeforen. 2004 Feb 5;124(3):332-4. Norwegian.

8.

[Surprising conclusion by the SBU concerning the benefits of naltrexone in the treatment of heroin dependence].

Heilig M.

Lakartidningen. 2002 Jan 17;99(3):200-4. Swedish. No abstract available.

PMID:
11838078
9.

Science and politics of heroin prescription.

Kerr T, Montaner JS, Wood E.

Lancet. 2010 May 29;375(9729):1849-50. doi: 10.1016/S0140-6736(10)60544-2. No abstract available.

PMID:
20511000
10.

[Documented effect of methadone, but not naltrexone].

Heilig M.

Lakartidningen. 2002 Feb 7;99(6):551-2. Swedish. No abstract available.

PMID:
11881232
11.

Netherlands considers prescribing heroin to addicts.

Sheldon T.

BMJ. 2002 Feb 16;324(7334):385. No abstract available.

12.

Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.

Strang J, Metrebian N, Lintzeris N, Potts L, Carnwath T, Mayet S, Williams H, Zador D, Evers R, Groshkova T, Charles V, Martin A, Forzisi L.

Lancet. 2010 May 29;375(9729):1885-95. doi: 10.1016/S0140-6736(10)60349-2.

PMID:
20511018
13.

Spain authorises clinical trial on heroin maintenance therapy.

Bosch X.

Lancet. 2001 Apr 28;357(9265):1347. No abstract available.

PMID:
11343756
14.

Methadone induction doses: are our current practices safe?

Srivastava A, Kahan M.

J Addict Dis. 2006;25(3):5-13.

PMID:
16956864
15.
16.
17.
18.

Prohibition of take-home dosages: negative consequences on methadone maintenance treatment.

Pani PP, Pirastu R, Ricci A, Gessa GL.

Drug Alcohol Depend. 1996 May;41(1):81-4.

PMID:
8793314
19.

Retention in a low-threshold methadone maintenance program.

Torrens M, Castillo C, Pérez-Solá V.

Drug Alcohol Depend. 1996 May;41(1):55-9.

PMID:
8793310
20.

The effectiveness and safety of methadone maintenance.

Ward J, Mattick RP, Hall W, Darke S.

Addiction. 1996 Nov;91(11):1727-9. No abstract available.

PMID:
8972930
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk